1. Csonka D, Zupkó I, Minorics R, Márki Á, Csík G, Falkay G. The effects of α-methyldopa on myometrial noradrenaline release and myometrial contractility in rat. Acta Obstet Gynecol Scand 2007;86(8):986-94. [
DOI:10.1080/00016340701463830]
2. Podjarny E, Benchetrit S, Katz B, Green J, Bernheim J. Effect of methyldopa on renal function in rats with L-NAME-induced hypertension in pregnancy. Nephron 2001;88(4):354-9. [
DOI:10.1159/000046020]
3. London ML, Olds SB, Ladewig PW, Ladewig PA, Davidson M. Clinical Handbook for Maternal Newborn Nursing and Women's Health Care: Prentice Hall; 2004.
4. Van Zwieten P, Thoolen M, Timmermans PB. The hypotensive activity and side effects of methyldopa, clonidine, and guanfacine. Hypertens 1984;6(5 Pt 2):28-33. [
DOI:10.1161/01.HYP.6.5_Pt_2.II28]
5. Wolf WA, Bobik A. α-Methyldopa metabolism in central serotonergic nerve terminals: effects on serotonin levels, synthesis and release. Eur J Pharmacol 1989;163(1):43-53. [
DOI:10.1016/0014-2999(89)90393-2]
6. Hess S, Connamacher R, Ozaki M, Udenfriend S. The effects of α-methyl-dopa and α-methyl-meta-tyrosine on the metabolism of norepinephrine and serotonin in vivo. J Pharmacol Exp Ther 1961;134(2):129-38.
7. Conway E, Jarrott B, Louis W. Effect of α-methyldopa on dopaminergic transmission in the corpus striatum. Neuropharmacology 1978;17(6):355-61. [
DOI:10.1016/0028-3908(78)90006-0]
8. Imaizumi R, Oka M, Ohuchi T. Mechanism of the Antihypertensive Effect of alpha-Methyldopa. Nature 1964;203:982-3. [
DOI:10.1038/203982a0]
9. González-Burgos I, Feria-Velasco A. Serotonin/dopamine interaction in memory formation. Prog Brain Res 2008;172:603-23. [
DOI:10.1016/S0079-6123(08)00928-X]
10. Birnbaum S, Gobeske KT, Auerbach J, Taylor JR, Arnsten AF. A role for norepinephrine in stress-induced cognitive deficits: α-1-adrenoceptor mediation in the prefrontal cortex. Biol Psychiatry 1999;46(9):1266-74. [
DOI:10.1016/S0006-3223(99)00138-9]
11. Buhot M-C, Martin S, Segu L. Role of serotonin in memory impairment. Ann Med 2000;32(3):210-21. [
DOI:10.3109/07853890008998828]
12. Jones H, Cummings A, Setchell K, Lawson A. A study of the disposition of alpha‐methyldopa in newborn infants following its administration to the mother for the treatment of hypertension during pregnancy. Br J Clin Pharmacol 1979;8(5):433-40. [
DOI:10.1111/j.1365-2125.1979.tb01022.x]
13. Solomon S, Hotchkiss E, Saravay SM, Bayer C, Ramsey P, Blum RS. Impairment of memory function by antihypertensive medication. Arch Gen Psychiatry 1983;40(10):1109-12. [
DOI:10.1001/archpsyc.1983.01790090071011]
14. Hosseini-Sharifabad A, Rabbani M, Sharifzadeh M, Bagheri N. Acute and chronic tramadol administration impair spatial memory in rat. Res Pharm Sci 2016;11(1):49.
15. Rutten K, Lieben C, Smits L, Blokland A. The PDE4 inhibitor rolipram reverses object memory impairment induced by acute tryptophan depletion in the rat. Psychopharmacology 2007;192(2):275-82. [
DOI:10.1007/s00213-006-0697-4]
16. Rutten K, Prickaerts J, Hendrix M, Van der Staay FJ, Şik A, Blokland A. Time-dependent involvement of cAMP and cGMP in consolidation of object memory: studies using selective phosphodiesterase type 2, 4 and 5 inhibitors. Eur J Pharmacol 2007;558(1):107-12. [
DOI:10.1016/j.ejphar.2006.11.041]
17. Khakpai F, Nasehi M, Haeri-Rohani A, Eidi A, Zarrindast MR. Scopolamine induced memory impairment; possible involvement of NMDA receptor mechanisms of dorsal hippocampus and/or septum. Behav Brain Res 2012;231(1):1-10. [
DOI:10.1016/j.bbr.2012.02.049]
18. Fan Y, Hu J, Li J, Yang Z, Xin X, Wang J, et al. Effect of acidic oligosaccharide sugar chain on scopolamine-induced memory impairment in rats and its related mechanisms. Neurosci Lett 2005;374(3):222-6. [
DOI:10.1016/j.neulet.2004.10.063]
19. Loizou L. Uptake of monoamines into central neurones and the blood‐brain barrier in the infant rat. Br J Pharmacol 1970;40(4):800-13. [
DOI:10.1111/j.1476-5381.1970.tb10656.x]
20. Boehm S, Huck S. α2-adrenoreceptor-mediated inhibition of acetylcholine-induced noradrenaline release from rat sympathetic neurons: An action at voltage-gated Ca 2+ channels. Neuroscience 1995;69(1):221-31. [
DOI:10.1016/0306-4522(95)00235-B]
21. Tellez S, Colpaert F, Marien M. α 2-Adrenoceptor modulation of cortical acetylcholine release in vivo. Neuroscience 1999;89(4):1041-50. [
DOI:10.1016/S0306-4522(98)00392-3]
22. Arnsten A, Cai JX, Goldman-Rakic PS. The alpha-2 adrenergic agonist guanfacine improves memory in aged monkeys without sedative or hypotensive side effects: evidence for alpha-2 receptor subtypes. J Neurosci 1988;8(11):4287-98.
23. Birnbaum S, Podell D, Arnsten A. Noradrenergic alpha-2 receptor agonists reverse working memory deficits induced by the anxiogenic drug, FG7142, in rats. Pharmacol Biochem Behav 2000;67(3):397-403. [
DOI:10.1016/S0091-3057(00)00306-3]